Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ovarian cancer vaccine - AVAX Technologies

Next Previous
X
Search
Drug Profile

Ovarian cancer vaccine - AVAX Technologies

Alternative Names: DNP-Modified Ovarian Cancer Vaccine; O-Vax; OVax

Latest Information Update: 25 Sep 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AVAX Technologies
  • Class Cancer vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ovarian cancer
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Ovarian cancer

Most Recent Events

  • 26 Jan 2016 Efficacy data from a phase I/II trial in Ovarian cancer (Second-line therapy or greater) released by AVAX Technologies
  • 21 Sep 2015 Phase-I/II development in Ovarian cancer is ongoing in USA
  • 04 Aug 2015 AVAX completes enrolment in a phase I/II trial for Ovarian cancer in USA (Intradermal)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top